You are here » Home » Markets » Stocks » Announcements

ANNOUNCEMENTS

Announcement for "Lincoln Pharmaceuticals Ltd"

Lincoln Pharmaceuticals Ltd Compliances-Reg.24(A)-Annual Secretarial Compliance

  • 20/05/2022
  • |
  • bse

Lincoln Pharmaceuticals Ltd Announcement under Regulation 30 (LODR)-Newspaper Publication

  • 20/05/2022
  • |
  • bse

Lincoln Pharmaceuticals Ltd Financial Result For The Quarter And Year Ended March 31 2022

  • 19/05/2022
  • |
  • bse

Lincoln Pharmaceuticals Ltd Board recommends Dividend

  • 19/05/2022
  • |
  • bse

Lincoln Pharmaceuticals Ltd Board Meeting Outcome for Outcome Of The Board Meeting

  • 19/05/2022
  • |
  • bse

Lincoln Pharmaceuticals Ltd Board to consider Dividend

  • 11/05/2022
  • |
  • bse

Lincoln Pharmaceuticals Ltd Board Meeting Intimation for Inter-Alia To Consider And Approve The Audited (Standalone And Consolid

  • 11/05/2022
  • |
  • bse

Lincoln Pharmaceuticals Ltd Format of Initial Disclosure to be made by an entity identified as a Large Corporate

  • 25/04/2022
  • |
  • bse

Lincoln Pharmaceuticals Ltd Certificate Under Regulation 40 (9) Of The SEBI (Listing Obligations And Disclosure Requirements) Re

  • 25/04/2022
  • |
  • bse

Lincoln Pharmaceuticals Ltd Compliance Certificate Under Regulation 7 (3) Of SEBI (LODR) For The Period Ended March 31 2022

  • 12/04/2022
  • |
  • bse

Lincoln Pharmaceuticals Ltd Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018

  • 11/04/2022
  • |
  • bse

Lincoln Pharmaceuticals Ltd Statement Of Investor Complaints For The Quarter Ended March 2022

  • 07/04/2022
  • |
  • bse

Lincoln Pharmaceuticals Ltd Closure of Trading Window

  • 31/03/2022
  • |
  • bse

Lincoln Pharmaceuticals Ltd Disclosures under Reg. 10(7) of SEBI (SAST) Regulations 2011

  • 23/03/2022
  • |
  • bse

Lincoln Pharmaceuticals Ltd Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011

  • 14/03/2022
  • |
  • bse

Lincoln Pharmaceuticals Ltd Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011

  • 14/03/2022
  • |
  • bse

Lincoln Pharmaceuticals Ltd Disclosures under Reg. 10(6) of SEBI (SAST) Regulations 2011

  • 14/03/2022
  • |
  • bse

Lincoln Pharmaceuticals Ltd Disclosures under Reg. 10(5) in respect of acquisition under Reg. 10(1)(a) of SEBI (SAST) Regulation

  • 04/03/2022
  • |
  • bse

Lincoln Pharmaceuticals Ltd Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011

  • 25/02/2022
  • |
  • bse

Lincoln Pharmaceuticals Ltd Announcement under Regulation 30 (LODR)-Newspaper Publication

  • 11/02/2022
  • |
  • bse
.